Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Sales | 7,630 | 16,357 | 18,346 | 23,466 | 23,911 |
| Cost of Goods | 4,575 | 2,624 | 2,379 | 3,596 | 2,204 |
| Gross Profit | 3,055 | 13,733 | 15,967 | 19,870 | 21,707 |
| Operating Expenses | 125,743 | 63,323 | 47,165 | 48,171 | 42,144 |
| Operating Income | -122,113 | -48,966 | -30,819 | -27,705 | -20,233 |
| Other Income | -485 | 318 | 483 | 481 | 34 |
| Pre-tax Income | -122,598 | -48,648 | -30,336 | -27,224 | -20,199 |
| Income Tax | 1,246 | -2,355 | 158 | 126 | 171 |
| Net Income Continuous | -123,844 | -46,293 | -30,494 | -27,350 | -20,370 |
| Net Income | $-123,844 | $-46,293 | $-30,494 | $-27,350 | $-20,370 |
| EPS Basic Total Ops | -1.66 | -0.62 | -0.41 | -0.37 | -0.28 |
| EPS Basic Continuous Ops | -1.66 | -0.62 | -0.41 | -0.37 | -0.28 |
| EPS Diluted Total Ops | -1.66 | -0.62 | -0.41 | -0.37 | -0.28 |
| EPS Diluted Continuous Ops | -1.66 | -0.62 | -0.41 | -0.37 | -0.28 |
| EPS Diluted Before Non-Recurring Items | -0.58 | -0.39 | -0.40 | -0.37 | -0.22 |
| EBITDA(a) | $-120,210 | $-47,157 | $-28,888 | $-25,871 | $-18,202 |